SWOT Analysis for Indo US Bio-Tech Ltd.

Upcoming results for Nifty500 companies with previous quarter net profit growth greater than 10% YoY and QoQ
Mid-range Performer (DVM)
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Companies with rising net profit margins - quarterly as well as TTM basis
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing profits every quarter for the past 3 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge

Negative Breakdown Third Support (LTP < S3)
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Low Piotroski Score : Companies with weak financials
Near 52 Week Low
Weak Momentum: Price below Short, Medium and Long Term Averages
Increasing Trend in Non-Core Income
RSI indicating price weakness
Highest fall from 52 Week High
Top Losers
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter